1. CAR T-cell therapy in hematological malignancies;Haslauer;Int J Mol Sci,2021
2. European Medicines Agency (EMA) . Available: https://www.ema.europa.eu/en/medicines [Accessed 26 May 2023].
3. Food and Drug Administration (FDA) . Authorized medicinal products, registry. 2022. Available: https://www.fda.gov/drugs [Accessed 25 May 2023].
4. Sehic O , Wild C . CAR-T Zell-Therapien in Entwicklung - Update 2022. AIHTA Policy Brief Nr: 006a; 1 Update 2022. Wien HTA Austria - Austrian Institute for Health Technology Assessment GmbH; 2022.
5. Strydom K , Gumafelix E . Delivering on the promise of CAR-T cell therapy: optimising the clinical trial process. World Scientific and IQVIA; 2023.